Lanzol® contains lansoprazole, a proton pump inhibitor, which indicated in cases of hydrochloric acid hypersecretion due to Zollinger – Ellison’s syndrome, for the maintenance treatment of patients with reflux esophagitis or duodenal ulcer and eradication of helicobacter pylori.

Product characteristics

Active ingredient: Lansoprazole

Pharmaceutical form / strength: gr.caps 30 mg/cap

Packaging: BT x 28 caps

pdf product presentation